NYSE: SNXTd Synnex Corp Stock
$117.38+0.14 (+0.12%)
Updated Apr 25, 2024
SNX Price
$117.38
Fair Value Price
N/A
Market Cap
$10.29B
52 Week Low
$86.30
52 Week High
$119.87
P/E
17.04x
P/B
1.27x
P/S
0.16x
PEG
N/A
Dividend Yield
1.28%
Revenue
$56.41B
Earnings
$632.02M
Gross Margin
7%
Operating Margin
1.91%
Profit Margin
1.1%
Debt to Equity
2.43
Operating Cash Flow
$2B
Beta
1.12
Next Earnings
Jun 25, 2024
Ex-Dividend
Apr 11, 2024
Next Dividend
Apr 26, 2024
SNX Overview
TD SYNNEX provides business process services in the U.S. and internationally. It distributes PC systems, mobile phones and accessories, printers, peripherals, supplies, endpoint technology software, consumer electronics, information technology systems including data center server and storage solutions, system components, software, networking, communications and security equipment, consumer electronics, and complementary products. Known as SYNNEX Corp. until 2021/09. TD SYNNEX was incorporated in 1980 and is headquartered in Fremont, CA.
Zen Score
–
Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNX was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNX is good value based on its earnings relative to its share price (17.04x), compared to the US market average (40.97x)
P/E vs Market Valuation
SNX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SNX due diligence checks available for Premium users.
Be the first to know about important SNX news, forecast changes, insider trades & much more!
SNX News
Valuation
SNX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.04x
Industry
13.09x
Market
40.97x
SNX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SNX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SNX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
1.35x
SNX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SNX's financial health
Profit margin
Revenue
$14.0B
Net Income
$172.1M
Profit Margin
1.2%
SNX's Earnings (EBIT) of $1.08B... subscribe to Premium to read more.
Interest Coverage Financials
SNX's profit margin (1.1%) has... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$27.8B
Liabilities
$19.7B
Debt to equity
2.43
SNX's short-term assets ($18.58B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNX's short-term assets ($18.58B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SNX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$384.7M
Investing
-$67.9M
Financing
-$311.2M
SNX's operating cash flow ($1.89B)... subscribe to Premium to read more.
Debt Coverage Financials
SNX vs Electronic & Computer Distribution Stocks
Td Synnex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.